ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
205.17
-8.18 (-3.83%)
At close: Apr 4, 2025, 4:00 PM
193.58
-11.59 (-5.65%)
After-hours: Apr 4, 2025, 8:00 PM EDT
ResMed Revenue
ResMed had revenue of $1.28B in the quarter ending December 31, 2024, with 10.26% growth. This brings the company's revenue in the last twelve months to $4.93B, up 9.38% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.
Revenue (ttm)
$4.93B
Revenue Growth
+9.38%
P/S Ratio
6.12
Revenue / Employee
$493,665
Employees
9,980
Market Cap
30.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RMD News
- 2 days ago - Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US - GlobeNewsWire
- 3 days ago - Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025 - GlobeNewsWire
- 3 days ago - My Top 15 High-Growth Dividend Stocks For April 2025 - Seeking Alpha
- 17 days ago - New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer - GlobeNewsWire
- 25 days ago - Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution - GlobeNewsWire
- 4 weeks ago - My Top 15 High-Growth Dividend Stocks For March 2025 - Seeking Alpha
- 5 weeks ago - ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep - GlobeNewsWire
- 7 weeks ago - Jan De Witte joins GHO Capital as Operating Partner - GlobeNewsWire